Is Tharimmune Inc (NASDAQ: THAR) Worth It? How Should Investors Deal With It?

During the last session, Tharimmune Inc (NASDAQ:THAR)’s traded shares were 61.19 million, with the beta value of the company hitting 1.51. At the end of the trading day, the stock’s price was $3.43, reflecting an intraday gain of 68.97% or $1.4. The 52-week high for the THAR share is $101.25, that puts it down -2851.9 from that peak though still a striking 46.36% gain since the share price plummeted to a 52-week low of $1.84. The company’s market capitalization is $3.94M, and the average intraday trading volume over the past 10 days was 6.16 million shares, and the average trade volume was 34.65K shares over the past three months.

Tharimmune Inc (THAR) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. THAR has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Tharimmune Inc (NASDAQ:THAR) trade information

Tharimmune Inc (THAR) registered a 68.97% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 68.97% in intraday trading to $3.43, hitting a weekly high. The stock’s 5-day price performance is 67.02%, and it has moved by 42.92% in 30 days. Based on these gigs, the overall price performance for the year is -94.14%. The short interest in Tharimmune Inc (NASDAQ:THAR) is 17697.0 shares and it means that shorts have 0.37 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -17.82%.

THAR Dividends

Tharimmune Inc is due to release its next quarterly earnings in November. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Tharimmune Inc (NASDAQ:THAR)’s Major holders

Tharimmune Inc insiders own 1.45% of total outstanding shares while institutional holders control 0.54%, with the float percentage being 0.55%.